Study of VX-770 and Rifampin in Healthy Male Subjects

Clinical trial NCT01018368 · COMPLETED

Trial details

NCT number: NCT01018368
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2009-11-01
Primary completion: 2010-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.